Bipolar Disorders (Pediatric) Clinical Trials

A listing of Bipolar Disorders (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 116 clinical trials
featured
Children and Adolescents with Bipolar I Disorder

Children and Adolescents with Bipolar I Disorder

  • 238 views
  • 08 Nov, 2020
  • 1 location
featured
Adolescents with Depression and/or Anxiety and a Parent or Sibling with Bipolar Disorder

Adolescents with Depression and/or Anxiety and a Parent or Sibling with Bipolar Disorder

  • 1594 views
  • 25 Mar, 2021
  • 1 location
Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs

A prospective, large, pragmatic, randomized trial to study the impact of METFORMIN and healthy lifestyle intervention (LIFE) vs. LIFE alone on patient-centered outcomes of body weight, SGA-adherence and satisfaction, psychiatric symptom burden (e.g. mood/anxiety), and Quality of Life.

aripiprazole
clozapine
olanzapine
paliperidone
risperidone
  • 212 views
  • 08 Jul, 2021
  • 30 locations
Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

This is a randomized, double-blind, placebo-controlled, multicentre, parallel-group study to assess the cognitive effects of lurasidone in bipolar I and II patients (manic depression) who are in remission from an episode. Participants who show cognitive impairment at the screening visit will be enrolled into the study and randomized at the …

bipolar i disorder
atypical antipsychotic
bipolar disorder
lurasidone
depressed mood
  • 491 views
  • 15 Jul, 2021
  • 10 locations
The CAG Bipolar the CAG Bipolar RCT

The CAG Bipolar study is a large-scale pragmatic randomized controlled trial aiming to investigate whether specialized and more centralized treatment (into a clinical academic group (CAG)) improves lives and outcomes for patients with bipolar disorder (N= 1000 patients).

bipolar disorder
  • 2 views
  • 24 Jan, 2021
  • 1 location
AKTIBIPO-VALIDATION: A Study to Validate Benefits of Mindpax System in Managing Bipolar Disorder

The aim of the AKTIBIPO VALIDATION study is to evaluate the effect of the Mindpax monitoring and microeducation system in patients with bipolar disorder (BD). Up to 130 participants (BD patients) who participated previously in the observational AKTIBIPO study will be enrolled for a follow-up period of 12 months. All …

  • 0 views
  • 10 Jul, 2021
  • 1 location
Optimal Electrical Stimulus During Electroconvulsive Therapy

Synopsis Aim: The purpose of the study is to determine the stimulus of electrical current during electroconvulsive therapy (ECT) that produces the optimal balance between antidepressant effect and memory disturbance. Specifically, this study aims to compare the 0.5 ms and 1.0 ms pulse width stimuli. Design: National, register-based randomized trial, …

depressive episode
depressed mood
antidepressants
suicide
electroconvulsive therapy
  • 98 views
  • 25 Jan, 2021
  • 2 locations
A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive With or Without Mixed Features

To evaluate the efficacy and safety of cariprazine at a target dose of 3.0 mg/d compared with placebo in prevention of relapse in patients with bipolar I disorder whose current episode (i.e. index episode) is manic or depressive, with or without mixed features; 2) To evaluate the efficacy and safety …

psychiatric disorder
mania
tension
bipolar i disorder
cariprazine
  • 8584 views
  • 01 Aug, 2021
  • 270 locations
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.

depressive disorder
schizophrenia
traumatic brain injury
bipolar disorder
major depressive disorder
  • 754 views
  • 26 Jan, 2021
  • 1 location
Recovering Damaged Cells for Sequelae Caused by COVID-19 SARS-CoV-2

Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the virus causes immune system function disorder and post-infectious autoimmune disease. The clinical symptoms can be smell loss, taste loss to liver function …

  • 0 views
  • 02 Jun, 2021
  • 1 location